FDA Letter API

RC Compounding Services, LLC

Letter data

Company
RC Compounding Services, LLC
Recipient
Raymond R. Carlson, RPh | Owner/Pharmacist | RC Compounding Services, LLC | 3030 Center Road | Poland | , | OH | 44514 | United States
Issue date
2019-09-12
Posted date
Not available
FDA office
Division of Pharmaceutical Quality Operations III
Subject
Not available
Product
Drugs
CMS ID
393791
Reference number
CIN-14-393791-17
FEI
Not available
Inspection dates
Not available

Normalized citations

21 CFR: None found

21 U.S.C.: None found

Related FDA links

No related FDA letter link is present in the source index.

Full source text

CLOSEOUT LETTER RC Compounding Services, LLC MARCS-CMS 393791 — September 12, 2019 More Warning Letters Warning Letters About Warning and Close-Out Letters Delivery Method: UPS Next Day Reference #: CIN-14-393791-17 Product: Drugs Recipient: Recipient Name Raymond R. Carlson, RPh Recipient Title Owner/Pharmacist RC Compounding Services, LLC 3030 Center Road Poland , OH 44514 United States Issuing Office: Division of Pharmaceutical Quality Operations III 300 River Place Suite 5900 Detroit , MI 48207 United States (313) 393-8100 Dear Mr. Carlson, The U.S. Food and Drug Administration (FDA) has completed an evaluation of your firm’s corrective actions in response to our warning letter dated July 14, 2014 (CIN-14-393791-17). Based on our evaluation, it appears that you have adequately addressed the violations contained in this warning letter. You are expected to take all necessary steps to ensure compliance with the Federal Food, Drug, and Cosmetic Act and FDA’s implementing regulations. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means. Sincerely, /S/ Nicholas F. Lyons Director Compliance Branch Division of Pharmaceutical Quality Operations III Content current as of: 10/24/2019 Regulated Product(s) Drugs